TLACPH Consulting ApS: Financial statements 2026
CVR: 40250360
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
TLACPH Consulting ApS (CVR 40250360) has filed annual accounts for 2026. In 2026, the company reported revenue of DKK 23,361 and a net result of DKK -31,833 compared with DKK 34,074 the year before. The profit margin was -136.3%. Equity in the 2026 report amounted to DKK 64,700. The solvency ratio was 23.5%.
- Revenue
- DKK 23,361
- Gross Profit
- DKK -15,532
- Profit/Loss
- DKK -31,833
- Equity
- DKK 64,700
- Total Assets
- DKK 274,941
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | 23K | -16K | -32K | 65K | - |
| 2025 | - | 36K | 34K | 152K | - |
| 2024 | 78K | 63K | 53K | 167K | 0 |
| 2023 | - | 176K | 226K | 314K | - |
| 2022 | - | 950K | 890K | 2.5M | - |
Official annual report
Find more companies like TLACPH Consulting ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout TLACPH Consulting ApS
TLACPH Consulting ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named TLACPH Consulting IVS and Norse Therapeutics IVS. The management consists of Thomas Lars Andresen. The company is owned by TLA-HOLDING 2010 ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2026, the company reported revenue of DKK 23,361 and a net result of DKK -31,833 compared with DKK 34,074 the year before. Equity in the 2026 report amounted to DKK 64,700.